This inventor holds 1 USPTO granted patent. Top assignee: Nexel Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Seulgi Yoon and Cardiac Safety Testing
Introduction
Seulgi Yoon is an inventor associated with Nexel Co., Ltd. in Seoul, South Korea. Her patent work focuses on evaluating the cardiac safety of drugs using cardiomyocytes derived from human stem cells.
Latest Patents
Yoon is named on 1 patent, titled “Methods for Evaluating Cardiac Safety of Drug Using Cardiomyocytes Derived from Human Stem Cells.” The method describes differentiating human stem cells into cardiomyocytes, preparing fibronectin-coated wells on a microelectrode array (MEA) plate, and measuring changes in beat rate, spike amplitude, and field potential duration after a drug is added. These measurements can help assess a drug’s potential cardiac effects.
Career Highlights
Yoon’s listed invention applies human stem cell-derived cardiomyocytes and MEA measurements to drug safety evaluation. Her work is associated with Nexel Co., Ltd.
Collaborations
Yoon’s listed coworkers include Donghun Woo and Jieun An.
Conclusion
Seulgi Yoon’s patent describes a cell-based approach to evaluating drug-related cardiac safety, using measurable electrical activity in human stem cell-derived cardiomyocytes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile